• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 4. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

4-Aminobutyramide Hydrochloride: A Comprehensive Overview

4-Aminobutyramide Hydrochloride, also known by its CAS number CAS No. 13031-62-4, is a compound that has garnered significant attention in the fields of pharmacology and biochemistry. This compound, which belongs to the class of amino acid derivatives, has been extensively studied for its potential applications in drug development and therapeutic interventions. Recent advancements in research have shed light on its unique properties and mechanisms of action, making it a subject of interest for both academia and industry.

The chemical structure of 4-Aminobutyramide Hydrochloride comprises a butyramide backbone with an amino group attached at the fourth carbon position. This structural arrangement imparts distinctive chemical properties, including its ability to interact with various biological systems. Researchers have explored its role in modulating cellular signaling pathways, particularly those involving neurotransmitters and neuromodulators. These findings have implications for treating conditions such as neurological disorders and metabolic diseases.

One of the most promising areas of research involving 4-Aminobutyramide Hydrochloride is its potential as a precursor to gamma-aminobutyric acid (GABA). GABA is a key inhibitory neurotransmitter in the central nervous system, playing a crucial role in regulating neuronal activity. Studies have demonstrated that this compound can be metabolized into GABA under specific physiological conditions, suggesting its utility in managing conditions associated with GABA deficiency, such as anxiety and epilepsy.

In addition to its neuropharmacological applications, 4-Aminobutyramide Hydrochloride has also been investigated for its metabolic effects. Recent studies indicate that it may influence energy metabolism by interacting with enzymes involved in lipid synthesis and degradation. This property has led to explorations into its potential as an adjunct therapy for obesity and related metabolic disorders.

The synthesis of 4-Aminobutyramide Hydrochloride involves a multi-step chemical process that ensures high purity and stability. Researchers have optimized synthetic protocols to enhance yield and minimize byproducts, making it more accessible for large-scale production. The compound's stability under various storage conditions further adds to its suitability for pharmaceutical applications.

From a regulatory standpoint, 4-Aminobutyramide Hydrochloride has undergone rigorous safety assessments to evaluate its toxicity profile. Preclinical studies suggest that it exhibits low toxicity at therapeutic doses, with minimal adverse effects observed in animal models. These findings are encouraging for its progression into clinical trials.

In conclusion, 4-Aminobutyramide Hydrochloride, CAS No. 13031-62-4, represents a versatile compound with diverse applications in medicine and pharmacology. Its ability to influence neurotransmitter systems and metabolic pathways positions it as a valuable tool in addressing a range of health conditions. As research continues to uncover new insights into its mechanisms and therapeutic potential, this compound is poised to play a significant role in future drug development efforts.

• 541-35-5(Butyramide)
• 110-14-5(butanediamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)